| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: A novel folate hydrolase
|
Heston, Warren D.W.
|
|
1997
|
49 |
3S1 |
p. 104-112
9 p.
|
artikel
|
| 2 |
Clinical significance of repeat sextant biopsies in prostate cancer patients
|
Stroumbakis, Nicholas
|
|
1997
|
49 |
3S1 |
p. 113-118
6 p.
|
artikel
|
| 3 |
Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure
|
D'Amico, Anthony V.
|
|
1997
|
49 |
3S1 |
p. 23-30
8 p.
|
artikel
|
| 4 |
Evaluating neoadjuvant therapy effectiveness on systemic disease: Use of a prostatic-specific membrane reverse transcription polymerase chain reaction
|
Su, Sai L.
|
|
1997
|
49 |
3S1 |
p. 95-101
7 p.
|
artikel
|
| 5 |
First International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: Overview consensus statement
|
Garnick, Marc B.
|
|
1997
|
49 |
3S1 |
p. 1-4
4 p.
|
artikel
|
| 6 |
Focal therapy for prostate cancer 1996: Maximizing outcome
|
Carroll, Peter R.
|
|
1997
|
49 |
3S1 |
p. 84-94
11 p.
|
artikel
|
| 7 |
Hormonal therapy in the management of prostate cancer: From Huggins to the present
|
Garnick, Marc B.
|
|
1997
|
49 |
3S1 |
p. 5-15
11 p.
|
artikel
|
| 8 |
Localized prostate cancer: Overview of surgical management
|
Richie, Jerome P.
|
|
1997
|
49 |
3S1 |
p. 35-37
3 p.
|
artikel
|
| 9 |
Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
|
Zelefsky, Michael J.
|
|
1997
|
49 |
3S1 |
p. 38-45
8 p.
|
artikel
|
| 10 |
Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
|
Zietman, Anthony L.
|
|
1997
|
49 |
3S1 |
p. 74-83
10 p.
|
artikel
|
| 11 |
Neoadjuvant hormonal therapy: The Canadian experience
|
Labrie, Fernand
|
|
1997
|
49 |
3S1 |
p. 56-64
9 p.
|
artikel
|
| 12 |
Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
|
Reuter, Victor E.
|
|
1997
|
49 |
3S1 |
p. 16-22
7 p.
|
artikel
|
| 13 |
Perspectives on prostate cancer treatment: Awareness, attitudes, and relationships
|
Porterfield, Henry A.
|
|
1997
|
49 |
3S1 |
p. 102-103
2 p.
|
artikel
|
| 14 |
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0 M0 prostatic carcinoma
|
Witjes, Wim P.J.
|
|
1997
|
49 |
3S1 |
p. 65-69
5 p.
|
artikel
|
| 15 |
PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer
|
McLeod, David G.
|
|
1997
|
49 |
3S1 |
p. 70-73
4 p.
|
artikel
|
| 16 |
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
|
Fair, William R.
|
|
1997
|
49 |
3S1 |
p. 46-55
10 p.
|
artikel
|
| 17 |
The role of color Doppler and staging biopsies in prostate cancer detection
|
Bree, Robert L.
|
|
1997
|
49 |
3S1 |
p. 31-34
4 p.
|
artikel
|
Tijdschrift beschrijving